FindTrial
Sign In

FISH application in the diagnosis and prognosis evaluation of myelodysplastic syndrome

FISH application in the diagnosis and prognosis evaluation of myelodysplastic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-11001709
Enrollment
Unknown
Registered
2011-11-11
Start date
2010-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myelodysplastic syndrome

Interventions

1:suporting therapy
2:hematopoietic stem cell transplantation
3:decitabine or 5-AZA
4:chemotherapy
5:others

Sponsors

Peking University People's Hospital, Peking University Institute of Hematology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: The newly diagnosed MDS patients according to Vienna criterion.

Exclusion criteria

Exclusion criteria: The patients do not reach the Vienna criterion of MDS.

Design outcomes

Primary

MeasureTime frame
FISH;chromosome karyotype;—

Countries

China

Contacts

Public ContactXiaojun Huang
xjhrm@medmail.com.cn+86 010 88326006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026